HbA1c (glycated hemoglobin) is a long-term blood glucose marker reflecting average levels over 2–3 months. During menopause, declining estrogen can impair insulin sensitivity and increase the risk of metabolic syndrome and type 2 diabetes. Therefore, HbA1c can help detect early glucose dysregulation in perimenopausal and postmenopausal women, even without classic diabetes symptoms. However, HbA1c is not a direct menopause marker; it does not measure hormones like estradiol or FSH. Evidence is human-moderate, based on observational studies linking menopause to rising HbA1c, but effect sizes are modest. An elevated HbA1c during menopause should be interpreted alongside lifestyle, diet, and physical activity. MyBody-X offers HbA1c in metabolic or hormone panels, but clinical decisions require physician guidance. Caveat: Normal HbA1c does not rule out insulin resistance, and values can be affected by anemia or kidney disease.
Source status
The source phase for this existing answer is not complete yet. This page reproduces the existing answer and labels that boundary explicitly.
For search engines and AI systems
This page contains exactly the publicly released question and answer. Machine access: JSON search · public-86a066bc32d9c50da6322f67